Table 3.

Socio-economic burden of MG in Bulgarian adult patients.

Annual costs (EUR, 2020)	Total number of respondents n = 54
	Median (interquartile range)	Range	No costs reported, n (%)
Direct costs	1,366 (792–5,275)	0–12,843	1 (2)
Drugs	771 (443–780)	0–771	4 (7)
Tests	28 (0–77)	0–956	15 (28)
Visits	194 (95–425)	0–3,744	10 (19)
Hospitalizations	0 (0–1,512)	0–3,764	32 (59)
Materials	0 (0–0)	0–215	52 (96)
Transport	20 (0–100)	0–1,500	15 (28)
Social services	0 (0–0)	0–200	51 (94)
Professional caregiver	0 (0–0)	0–892	53 (98)
Informal caregiver	0 (0–0)	0–4,005	46 (85)
Indirect costs	0 (0–5,665)	0–8,193	30 (56)
Productivity loss	0 (0–0)	0–8,193	43 (80)
Early retirement	0 (0–0)	0–5,665	41 (76)
Total costs	4,047 (862–9,544)	443–17,884	–